{"nct_id":"NCT06018428","title":"A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)","status":"RECRUITING","status_verified_date":"2025-08","start_date":"2023-09-12","start_date_type":"ACTUAL","primary_completion_date":"2026-06","primary_completion_date_type":"ESTIMATED","completion_date":"2026-09","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["QTTB"]}